Professor Alex Fornito
Head of the Brain Mapping and Modelling Research Program
Turner Institute for Brain and Mental Health, Monash University
VICTORIA, AUSTRALIA
Bench Side Story continues with a Professor and Head of the Brain Mapping and Modelling Research Program at the Turner Institute for Brain and Mental Health, at Monash University in Melbourne, Victoria, AUSTRALIA.
Professor Alex Fornito completed his Clinical Masters (Neuropsychology) and PhD in 2007 in the Departments of Psychiatry and Psychology at The University of Melbourne before undertaking Post-Doctoral training in the Department of Psychiatry at the University of Cambridge, UK, under the auspices of an NHMRC Training Fellowship. He is currently a Sylvia and Charles Viertel Foundation Senior Research Fellow, co-Director of the Brain, Mind and Society Research Hub and Head of the Brain Mapping and Modelling Research Program at the Turner Institute for Brain and Mental Health.
Professor Fornito’s research concentrates on developing new imaging techniques for mapping human brain connectivity and applying these methods to shed light on brain function in health and disease. A major emphasis of his work concerns understanding foundational principles of brain organization and their genetic basis; characterizing brain connectivity disturbances in psychiatric disorders such as schizophrenia; and mapping how brain networks dynamically reconfigure in response to changing task demands.
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
-
Public health and research into Ear, Nose and Throat conditions
Associate Professor Paul Paddle is an Ear, Nose and Throat (ENT) surgeon, head and neck surgeon with fellowship training in Laryngology – Voice, airway and Swallowing disorders. Working at Monash Health and Monash Children’s hospital, Paul has extensive experience managing a wide range of paediatric ENT conditions, from neonates to adolescents. He is also an active researcher in paediatric obstructive sleep apnoea and sleep disorders.
-
Better biomarkers for predicting the incidence of having atherosclerosis and heart attack
Assoc Prof Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called chemokines.
